GPRC5D-specific MM cell cytotoxicity, and CD4 + T and CD8 + T cell activation were observed in a dose-dependent manner in cell lines with different GPRC5D expression levels (Fig. 2c). The gene discussed is CD4; the disease is Miyoshi myopathy.